At the translational level in an independent Prostate Adenocarcinoma cohort (350 tumors) from The Cancer Proteome Atlas (TCPA) consortium [49,50], reverse phase protein array analysis demonstrated that STMN1 protein expression and phosphorylated MET-pY1235 protein expression showed a strong positive correlation (p = 2.2 × 10−16) (Figure 1B). The gene discussed is MET; the disease is prostate adenocarcinoma.